Article info
PDFClinical science
Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)—study protocol
- Correspondence to Professor Augusto Azuara-Blanco, Centre for Public Health, Queen's University Belfast, Belfast BT12 6BA, UK; a.azuara-blanco{at}qub.ac.uk
Citation
Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)—study protocol
Publication history
- Received June 26, 2019
- Revised September 9, 2019
- Accepted October 5, 2019
- First published October 25, 2019.
Online issue publication
June 23, 2020
Article Versions
- Previous version (23 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.